Assessment of patients with chronic obstructive pulmonary disease (COPD) in GOLD 2011/2013: More grey zones or a step towards better management?

Konstantinos Kostikas; Petros Bakakos; Stelios Loukides

2/2013 vol. 26

EDITORIAL

Konstantinos Kostikas ¹

Petros Bakakos ¹

Stelios Loukides ¹

More details

Hide details

Editorial Board, Pneumon

Corresponding author

Konstantinos Kostikas

Stamouli 3, Karditsa 43100

Pneumon 2013;26(2):123-126

Article (PDF)

References (16)

REFERENCES (16)

Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55.

Google Scholar

Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013;187:347-65.

Google Scholar

Global Strategy for Diagnosis, Management and Prevention of COPD. 2013. (Accessed June 16, 2013, at http://www.goldcopd.org/Guidel....).

Google Scholar

Kostikas K, Hillas G, Michaelides SA, Kontakiotis T, Kosmas EN, Tzanakis N. Chronic obstructive pulmonary disease. Pneumon 2012;25:9-24.

Google Scholar

Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P, Salcedo E, Navarro M, Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005;60:925-31.

Google Scholar

Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.

Google Scholar

Agusti A, Hurd S, Jones P, et al. Frequently asked questions (FAQs) about the GOLD 2011 assessment proposal of COPD. Eur Respir J 2013. [Epub ahead of print].

Google Scholar

Wedzicha JA. GOLD and ABCD—a good start, but now for the evidence? Lancet Respir Med 2013:4-5.

Google Scholar

Rabe KF, Cooper CB. Global initiative on obstructive lung disease revised. Am J Respir Crit Care Med 2013;187:1035-6.

Google Scholar

10.

Agusti A, Edwards LD, Celli B, et al. Characteristics, stability and outcomes of the GOLD 2011 COPD groups in the ECLIPSE cohort. Eur Respir J 2013. [Epub ahead of print].

Google Scholar

11.

Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classifi cation in COPDGene: a prospective cohort study. Lancet Respir Med 2013:43-50.

Google Scholar

12.

Johannessen A, Nilsen RM, Storebo M, Gulsvik A, Eagan T, Bakke P. Comparison of 2011 and 2007 GOLD Guidelines for Predicting Mortality and Hospitalization. Am J Respir Crit Care Med 2013. [Epub ahead of print].

Google Scholar

13.

Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186:975-81.

Google Scholar

14.

Leivseth L, Brumpton BM, Nilsen TI, Mai XM, Johnsen R, Langhammer A. GOLD classifications and mortality in chroni obstructive pulmonary disease: the HUNT Study, Norway. Thorax 2013. [Epub ahead of print].

Google Scholar

15.

Soriano JB, Alfageme I, Almagro P, et al. Distribution and prognostic validity of the new global initiative for chronic obstructive lung disease grading classification. Chest 2013;143:694-702.

Google Scholar

16.

Papaioannou AI, Bartziokas K, Tsikrika S, et al. The impact of depressive symptoms on recovery and outcome of hospitalised COPD exacerbations. Eur Respir J 2013;41:815-23.

Google Scholar

Submit your paper

Instructions to Authors

Issues

Indexes

eISSN:	1791-4914
ISSN:	1105-848X